150 related articles for article (PubMed ID: 342554)
1. A topical treatment program for psoriasis with low anthralin concentrations.
Brody I; Johansson A
J Cutan Pathol; 1977 Oct; 4(5):233-43. PubMed ID: 342554
[TBL] [Abstract][Full Text] [Related]
2. [Effect of coal tar on cignolin erythema--1 hour treatment of psoriasis with high-dose cignolin with and without tar].
Schauder S; Mahrle G
Z Hautkr; 1985 Jun; 60(11):875-83. PubMed ID: 3160177
[TBL] [Abstract][Full Text] [Related]
3. Detection of anthralin in skin during treatment.
Juhlin L; Schroot B
Acta Derm Venereol Suppl (Stockh); 1985; 120():27-9. PubMed ID: 3869415
[TBL] [Abstract][Full Text] [Related]
4. [A new method of local treatment of psoriasis].
Brody I
Lakartidningen; 1979 Feb; 76(9):730-2. PubMed ID: 763042
[No Abstract] [Full Text] [Related]
5. Anthralin for psoriasis: short-contact anthralin therapy compared with topical steroid and conventional anthralin.
Lowe NJ; Ashton RE; Koudsi H; Verschoore M; Schaefer H
J Am Acad Dermatol; 1984 Jan; 10(1):69-72. PubMed ID: 6693604
[TBL] [Abstract][Full Text] [Related]
6. The influence of treatment of the paralesional skin with dithranol on healing in psoriasis.
Stankler L; Dave VK
Br J Dermatol; 1975 Jan; 92(1):57-61. PubMed ID: 1098687
[TBL] [Abstract][Full Text] [Related]
7. Measurement of the response of psoriasis to short-term application of anthralin.
Marsden JR; Coburn PR; Marks J; Shuster S
Br J Dermatol; 1983 Aug; 109(2):209-18. PubMed ID: 6871098
[TBL] [Abstract][Full Text] [Related]
8. Treatment of psoriasis vulgaris: gentleness to the entire psoriatic skin and the use of low concentrations of anthralin.
Brody I
Br J Dermatol; 1981 Aug; 105 Suppl 20():109-10. PubMed ID: 7284255
[No Abstract] [Full Text] [Related]
9. Anthralin cream as short contact therapy for psoriasis.
Miller AC
Cutis; 1985 Jun; 35(6):578-82. PubMed ID: 4017653
[TBL] [Abstract][Full Text] [Related]
10. Dithranol-UV-A phototherapy (DUVA) for psoriasis: a treatment without dressings.
Hindson C; Diffey B; Lawlor F; Downey A
Br J Dermatol; 1983 Apr; 108(4):457-60. PubMed ID: 6838770
[TBL] [Abstract][Full Text] [Related]
11. Short contact anthralin in the treatment of psoriasis: a study of different contact times.
MacDonald KJ; Marks J
Br J Dermatol; 1986 Feb; 114(2):235-9. PubMed ID: 3947539
[TBL] [Abstract][Full Text] [Related]
12. Anthralin therapy for psoriasis. A new look at an old compound.
Gorsulowsky DC; Voorhees JJ; Ellis CN
Arch Dermatol; 1985 Dec; 121(12):1509-11. PubMed ID: 4062331
[No Abstract] [Full Text] [Related]
13. Mast cell alterations in chronic psoriasis vulgaris: response to low-strength anthralin treatment. A transmission electron microscopic study.
Brody I
Ups J Med Sci; 1986; 91(1):1-16. PubMed ID: 3716018
[TBL] [Abstract][Full Text] [Related]
14. [A very promising treatment method in psoriasis. Short-term anthralin therapy].
Kunze J; Petres J
Fortschr Med; 1981 May; 99(20):761-4. PubMed ID: 7262756
[TBL] [Abstract][Full Text] [Related]
15. [Topical treatment of psoriasis].
Suhonen R
Duodecim; 1985; 101(11):1135-41. PubMed ID: 4017905
[No Abstract] [Full Text] [Related]
16. A comparative study of calcipotriol and anthralin for chronic plaque psoriasis in a day care treatment center.
Dutz JP; Lui H
Int J Dermatol; 1998 Jan; 37(1):51-3. PubMed ID: 9522242
[TBL] [Abstract][Full Text] [Related]
17. Short contact anthralin therapy of psoriasis with and without UV-irradiation and maintenance schedule to prevent relapses.
Brun P; Juhlin L; Schalla W
Acta Derm Venereol; 1984; 64(2):174-7. PubMed ID: 6203312
[TBL] [Abstract][Full Text] [Related]
18. New chemical stabilizers, vehicles and delivery systems to enhance efficacy of low strength anthralin formulations.
van Scott EJ; Yu RJ
Br J Dermatol; 1981 Aug; 105 Suppl 20():35-8. PubMed ID: 7284262
[No Abstract] [Full Text] [Related]
19. Low strength anthralin in psoriasis.
Montes LF; Wilborn WH; Brody I
J Cutan Pathol; 1979 Dec; 6(6):445-56. PubMed ID: 42654
[TBL] [Abstract][Full Text] [Related]
20. A comparison between Antraderm stick (0.5% and 1%) and dithranol paste (0.125% and 0.25%) in the treatment of psoriasis.
Agrup G; Agdell J
Br J Clin Pract; 1985 May; 39(5):185-7. PubMed ID: 3907683
[No Abstract] [Full Text] [Related]
[Next] [New Search]
